- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 4 Reference Ions Near m/z 573.3356
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000056634 Reliable | 573.3324 | 573.3321 ~ 573.3329 MzDiff: 3.3 ppm |
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide (BioDeep_00000180590) Formula: C33H43N5O4 (573.3315) |
5.75 (100%) | DESI [NOVOCELL:BACKGROUND] blank |
MSI_000027544 Unreliable | 573.3356 | 573.3355 ~ 573.3356 MzDiff: 0.1 ppm |
Tazemetostat (BioDeep_00000229512) Formula: C34H44N4O4 (572.3362) |
3.07 (100%) | Mus musculus [UBERON:0002048] lung |
MSI_000004140 Unreliable | 573.3357 | 573.3357 ~ 573.3357 MzDiff: none |
Tazemetostat (BioDeep_00000229512) Formula: C34H44N4O4 (572.3362) |
0.98 (100%) | Homo sapiens [UBERON:0002107] liver |
MSI_000056975 Unreliable | 573.3391 | 573.3391 ~ 573.3391 MzDiff: none |
Tazemetostat (BioDeep_00000229512) Formula: C34H44N4O4 (572.3362) |
1.51 (100%) | Homo sapiens [UBERON:0007779] transudate |
Found 14 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
Tazemetostat Formula: C34H44N4O4 (572.3362) Adducts: [M+H]+ (Ppm: 13.6) |
Homo sapiens (Liver) |
20171107_FIT4_DHBpos_p70_s50Resolution: 50μm, 70x70
|
|
Tazemetostat Formula: C34H44N4O4 (572.3362) Adducts: [M+H]+ (Ppm: 14.7) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
Tazemetostat Formula: C34H44N4O4 (572.3362) Adducts: [M+H]+ (Ppm: 14) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
Tazemetostat Formula: C34H44N4O4 (572.3362) Adducts: [M+H]+ (Ppm: 13.8) |
Mus musculus (Lung) |
image2Resolution: 40μm, 550x256
Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b)
[PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9-
choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in
parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in
white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar
regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids
PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using
total ion current normalisation and hotspot removal (high quantile = 99%). |
|
m/z_573.3333 Formula: - (n/a) Adducts: (Ppm: 0) |
Homo sapiens (esophagus) |
LNTO22_1_4Resolution: 17μm, 82x80
|
|
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide Formula: C33H43N5O4 (573.3315) Adducts: [M]+ (Ppm: 3.4) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
Tazemetostat Formula: C34H44N4O4 (572.3362) Adducts: [M+H]+ (Ppm: 7.4) |
Homo sapiens (colorectal adenocarcinoma) |
80TopL, 50TopR, 70BottomL, 60BottomR-profileResolution: 17μm, 137x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
24-Acetyl- 25-cinnamoylvulgaroside Formula: C36H48O8 (608.3349) Adducts: [M+H-2H2O]+ (Ppm: 17.4) |
Homo sapiens (colorectal adenocarcinoma) |
520TopL, 490TopR, 510BottomL, 500BottomR-profileResolution: 17μm, 147x131
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
Tazemetostat Formula: C34H44N4O4 (572.3362) Adducts: [M+H]+ (Ppm: 16.9) |
Homo sapiens (colorectal adenocarcinoma) |
439TopL, 409TopR, 429BottomL, 419BottomR-profileResolution: 17μm, 157x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide Formula: C33H43N5O4 (573.3315) Adducts: [M]+ (Ppm: 1.2) |
Homo sapiens (esophagus) |
LNTO29_16_3Resolution: 17μm, 108x107
|
|
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide Formula: C33H43N5O4 (573.3315) Adducts: [M]+ (Ppm: 1.3) |
Homo sapiens (esophagus) |
TO31TResolution: 75μm, 56x54
|
|
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide Formula: C33H43N5O4 (573.3315) Adducts: [M]+ (Ppm: 2.5) |
Homo sapiens (esophagus) |
TO29TResolution: 75μm, 56x48
|
|
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide Formula: C33H43N5O4 (573.3315) Adducts: [M]+ (Ppm: 2) |
Homo sapiens (esophagus) |
LNTO30_17_2Resolution: 75μm, 82x54
|
|
N-Acetyl-N-[(2S)-3-(1H-indol-3-yl)-2-[[2-(4-piperidin-1-ylpiperidin-1-yl)acetyl]amino]propyl]-2-methoxybenzamide Formula: C33H43N5O4 (573.3315) Adducts: [M]+ (Ppm: 2.5) |
Homo sapiens (esophagus) |
LNTO22_1_7Resolution: 75μm, 69x54
|
|